Retroviral RLI/4-1 BBL and RLI/FLT3L Combination Immunomodulatory Gene Therapy for Glioblastoma

NIH RePORTER · NIH · R01 · $95,027 · view on reporter.nih.gov ↗

Abstract

PROJECT SUMMARY/ABSTRACT This proposed project is within the scope of R01NS123808. There are no changes to the Project Summary/Narrative of the Parent Award. A brief description of the Parent Grant Specific Aims is provided within the Research and Career Plan.

Key facts

NIH application ID: 10740288
Project number: 3R01NS123808-01A1S1
Recipient: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Principal Investigator: Manish Aghi
Activity code: R01
Funding institute: NIH
Fiscal year: 2023
Award amount: $95,027
Award type: 3
Project period: 2023-02-15 → 2023-12-31